Corrigendum
Corrigendum to “Retrospective Observational Study on Rebamipide Ophthalmic Suspension on Quality of Life of Dry Eye Disease Patients”
Table 2
DEQS questionnaire score at each visit.
| DEQS questionnaire score | 1 month, n = 25 | 3 months, n = 17 | 6 months, n = 19 | 12 months, n = 9 | 24 months, n = 8 | Before | 1M | value | Before | 3M | value | Before | 6M | value | Before | 12M | value | Before | 24M | value |
| Summary score | 43.0 (23.6) | 34.2 (24.6) | 0.008 | 44.5 (24.1) | 39.8 (24.8) | 0.018 | 53.2 (20.0) | 34.4 (20.8) | 0.001 | 47.4 (16.3) | 33.3 (17.1) | 0.049 | 41.0 (20.3) | 34.4 (12.1) | 0.58 | Bothersome ocular symptoms score | 51.4 (24.4) | 37.7 (23.2) | 0.019 | 53.9 (23.9) | 42.9 (28.3) | 0.016 | 57.5 (25.9) | 41.5 (21.7) | 0.02 | 49.5 (19.4) | 39.4 (23.8) | 0.180 | 41.1 (24.7) | 42.2 (16.0) | 0.82 | Impact on daily life score | 38.2 (26.9) | 31.9 (27.1) | 0.014 | 42.0 (26.6) | 37.7 (24.8) | 0.004 | 43.3 (20.5) | 29.8 (21.7) | 0.001 | 46.0 (17.2) | 29.3 (19.1) | 0.034 | 39.7 (19.2) | 29.2 (13.8) | 0.40 |
|
|
Values are the means (±SDs). One sample paired t-test was used for statistical comparisons.
|